Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Endogenously-Produced Hyaluronan and Its Potential to Regulate the Development of Peritoneal Adhesions

A. Kocurkova, K. Nesporova, M. Sandanusova, M. Kerberova, K. Lehka, V. Velebny, L. Kubala, G. Ambrozova

. 2021 ; 12 (1) : . [pub] 20211229

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc22019596

Formation of peritoneal adhesions (PA) is one of the major complications following intra-abdominal surgery. It is primarily caused by activation of the mesothelial layer and underlying tissues in the peritoneal membrane resulting in the transition of mesothelial cells (MCs) and fibroblasts to a pro-fibrotic phenotype. Pro-fibrotic transition of MCs-mesothelial-to-mesenchymal transition (MMT), and fibroblasts activation to myofibroblasts are interconnected to changes in cellular metabolism and culminate in the deposition of extracellular matrix (ECM) in the form of fibrotic tissue between injured sides in the abdominal cavity. However, ECM is not only a mechanical scaffold of the newly synthetized tissue but reciprocally affects fibrosis development. Hyaluronan (HA), an important component of ECM, is a non-sulfated glycosaminoglycan consisting of N-acetyl-D-glucosamine (GlcNAc) and D-glucuronic acid (GlcUA) that can affect the majority of processes involved in PA formation. This review considers the role of endogenously produced HA in the context of different fibrosis-related pathologies and its overlap in the development of PA.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22019596
003      
CZ-PrNML
005      
20220804135815.0
007      
ta
008      
220720s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/biom12010045 $2 doi
035    __
$a (PubMed)35053193
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Kocurkova, Anna $u Institute of Biophysics, Academy of Sciences of the Czech Republic, 612 65 Brno, Czech Republic $u Institute of Experimental Biology, Faculty of Science, Masaryk University, 611 37 Brno, Czech Republic $u International Clinical Research Center, St. Anne's University Hospital, 656 91 Brno, Czech Republic
245    10
$a Endogenously-Produced Hyaluronan and Its Potential to Regulate the Development of Peritoneal Adhesions / $c A. Kocurkova, K. Nesporova, M. Sandanusova, M. Kerberova, K. Lehka, V. Velebny, L. Kubala, G. Ambrozova
520    9_
$a Formation of peritoneal adhesions (PA) is one of the major complications following intra-abdominal surgery. It is primarily caused by activation of the mesothelial layer and underlying tissues in the peritoneal membrane resulting in the transition of mesothelial cells (MCs) and fibroblasts to a pro-fibrotic phenotype. Pro-fibrotic transition of MCs-mesothelial-to-mesenchymal transition (MMT), and fibroblasts activation to myofibroblasts are interconnected to changes in cellular metabolism and culminate in the deposition of extracellular matrix (ECM) in the form of fibrotic tissue between injured sides in the abdominal cavity. However, ECM is not only a mechanical scaffold of the newly synthetized tissue but reciprocally affects fibrosis development. Hyaluronan (HA), an important component of ECM, is a non-sulfated glycosaminoglycan consisting of N-acetyl-D-glucosamine (GlcNAc) and D-glucuronic acid (GlcUA) that can affect the majority of processes involved in PA formation. This review considers the role of endogenously produced HA in the context of different fibrosis-related pathologies and its overlap in the development of PA.
650    _2
$a epitel $7 D004848
650    _2
$a fibroblasty $x fyziologie $7 D005347
650    12
$a kyselina hyaluronová $x metabolismus $7 D006820
650    _2
$a myofibroblasty $x metabolismus $7 D058628
650    12
$a peritoneum $x metabolismus $7 D010537
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Nesporova, Kristina $u Contipro a.s., Dolní Dobrouč 401, 561 02 Dolní Dobrouč, Czech Republic
700    1_
$a Sandanusova, Miriam $u Institute of Biophysics, Academy of Sciences of the Czech Republic, 612 65 Brno, Czech Republic $u Institute of Experimental Biology, Faculty of Science, Masaryk University, 611 37 Brno, Czech Republic $u International Clinical Research Center, St. Anne's University Hospital, 656 91 Brno, Czech Republic
700    1_
$a Kerberova, Michaela $u Institute of Biophysics, Academy of Sciences of the Czech Republic, 612 65 Brno, Czech Republic
700    1_
$a Lehka, Katerina $u Contipro a.s., Dolní Dobrouč 401, 561 02 Dolní Dobrouč, Czech Republic
700    1_
$a Velebny, Vladimir $u Contipro a.s., Dolní Dobrouč 401, 561 02 Dolní Dobrouč, Czech Republic
700    1_
$a Kubala, Lukas $u Institute of Biophysics, Academy of Sciences of the Czech Republic, 612 65 Brno, Czech Republic $u Institute of Experimental Biology, Faculty of Science, Masaryk University, 611 37 Brno, Czech Republic $u International Clinical Research Center, St. Anne's University Hospital, 656 91 Brno, Czech Republic $1 https://orcid.org/0000000277297338 $7 xx0094314
700    1_
$a Ambrozova, Gabriela $u Institute of Biophysics, Academy of Sciences of the Czech Republic, 612 65 Brno, Czech Republic $1 https://orcid.org/0000000281729746
773    0_
$w MED00188737 $t Biomolecules $x 2218-273X $g Roč. 12, č. 1 (2021)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35053193 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20220804135808 $b ABA008
999    __
$a ok $b bmc $g 1822986 $s 1170839
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 12 $c 1 $e 20211229 $i 2218-273X $m Biomolecules $n Biomolecules $x MED00188737
LZP    __
$a Pubmed-20220720
Zpět

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace